NYSE:BIOLife Sciences
Bio Rad Laboratories (BIO) Following ddPCR Expansion Narrative Looks Fully Valued
Bio-Rad Laboratories (BIO) has drawn investor attention after recent share moves, with the stock up 0.8% on the day and 6.5% over the past week, despite a decline over the past month.
See our latest analysis for Bio-Rad Laboratories.
Set against a 1 year total shareholder return of 23.3% but a 5 year total shareholder return that is down 54.9%, Bio-Rad Laboratories’ recent 6.5% 7 day share price gain after a weaker 30 day share price return suggests short term momentum is improving, while...